Powered by OpenAIRE graph
Found an issue? Give us feedback
image/svg+xml Jakob Voss, based on art designer at PLoS, modified by Wikipedia users Nina and Beao Closed Access logo, derived from PLoS Open Access logo. This version with transparent background. http://commons.wikimedia.org/wiki/File:Closed_Access_logo_transparent.svg Jakob Voss, based on art designer at PLoS, modified by Wikipedia users Nina and Beao Archivio Istituziona...arrow_drop_down
image/svg+xml Jakob Voss, based on art designer at PLoS, modified by Wikipedia users Nina and Beao Closed Access logo, derived from PLoS Open Access logo. This version with transparent background. http://commons.wikimedia.org/wiki/File:Closed_Access_logo_transparent.svg Jakob Voss, based on art designer at PLoS, modified by Wikipedia users Nina and Beao
image/svg+xml Jakob Voss, based on art designer at PLoS, modified by Wikipedia users Nina and Beao Closed Access logo, derived from PLoS Open Access logo. This version with transparent background. http://commons.wikimedia.org/wiki/File:Closed_Access_logo_transparent.svg Jakob Voss, based on art designer at PLoS, modified by Wikipedia users Nina and Beao
versions View all 3 versions
addClaim

Frictional purpuric eruption associated with angiotensin II receptor blockers.

Authors: Foti, C.; Carbonara, A. M.; GUIDA, STEFANIA; Antelmi, A.; Mazzocca, A.; Romita, P.; Bonamonte, D.; +1 Authors

Frictional purpuric eruption associated with angiotensin II receptor blockers.

Abstract

Angiotensin II receptor blockers (ARBs) are drugs generally well tolerated. There are few reports about cutaneous side effects of ARBs. The present authors describe herein four cases of purpuric eruption mainly involving sites of friction in patients taking ARBs. These eruptions completely cleared after stopping the drug and implementing preservative measures to reduce friction. © 2013 Wiley Periodicals, Inc.

Angiotensin II receptor blockers (ARBs) are drugs generally well tolerated. There are few reports about cutaneous side effects of ARBs. The present authors describe herein four cases of purpuric eruption mainly involving sites of friction in patients taking ARBs. These eruptions completely cleared after stopping the drug and implementing preservative measures to reduce friction.

Country
Italy
Keywords

Male, hand palm, very elderly, friction, angiotensin 1 receptor antagonist, irbesartan, middle aged, 80 and over, zofenopril, forearm, Aged, 80 and over, angiotensin II receptor blockers, non insulin dependent diabetes mellitus, Drug Substitution, adult, article, Middle Aged, hydrochlorothiazide, aged, female, colon cancer, drug substitution, drug withdrawal, Hypertension, antihypertensive agent, chemically induced, Female, Drug Eruptions, cutaneous side effects, hypertension, Friction, atenolol; hydrochlorothiazide; irbesartan; nickel sulfate; repaglinide; valsartan; zofenopril; angiotensin 1 receptor antagonist; antihypertensive agent, adult; aged; article; asymptomatic disease; case report; colon cancer; consultation; drug substitution; drug withdrawal; female; forearm; friction; hand palm; human; human tissue; hypertension; microbiological examination; middle aged; non insulin dependent diabetes mellitus; patient history of surgery; purpuric rash; skin allergy; skin biopsy; treatment duration; chemically induced; Drug Eruptions; Exanthema; male; very elderly, Aged, 80 and over; Angiotensin II Type 1 Receptor Blockers; Antihypertensive Agents; Drug Eruptions; Drug Substitution; Exanthema; Female; Friction; Humans; Hypertension; Male; Middle Aged; angiotensin II receptor blockers; cutaneous side effects; purpuric dermatitis, valsartan, male, consultation, case report, Humans, human, skin biopsy, Antihypertensive Agents, purpuric rash, Aged, repaglinide, treatment duration, asymptomatic disease, skin allergy, Exanthema, atenolol, human tissue, nickel sulfate, patient history of surgery, purpuric dermatitis, microbiological examination, Angiotensin II Type 1 Receptor Blockers

  • BIP!
    Impact byBIP!
    selected citations
    These citations are derived from selected sources.
    This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).
    6
    popularity
    This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network.
    Average
    influence
    This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).
    Top 10%
    impulse
    This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network.
    Average
Powered by OpenAIRE graph
Found an issue? Give us feedback
selected citations
These citations are derived from selected sources.
This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).
BIP!Citations provided by BIP!
popularity
This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network.
BIP!Popularity provided by BIP!
influence
This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).
BIP!Influence provided by BIP!
impulse
This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network.
BIP!Impulse provided by BIP!
6
Average
Top 10%
Average
Related to Research communities
Cancer Research
Upload OA version
Are you the author of this publication? Upload your Open Access version to Zenodo!
It’s fast and easy, just two clicks!